论文部分内容阅读
β受体阻滞剂自从上世纪50年代开始用于临床以来,一直在心血管领域占据极其重要的地位。正如李立环教授在文中提到的,到目前为止,还没有一类药物像β受体阻滞剂那样产生如
Beta blockers have been of central importance in the cardiovascular field since they were introduced to the clinic in the 1950s. As Professor Li Lihuan mentioned in the article, so far, no class of drugs such as β-blockers do not produce such as